NCT00547196View on ClinicalTrials.gov

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 16, 2005

Primary Completion Date

November 11, 2009

Study Completion Date

May 28, 2024

Conditions

LeukemiaLymphomaMyelodysplastic Syndromes

Interventions

BIOLOGICAL

filgrastim

DRUG

Busulfan

DRUG

Cyclophosphamide

DRUG

Cyclosporine

DRUG

Fludarabine phosphate

DRUG

Melphalan

DRUG

Mycophenolate Mofetil

PROCEDURE

allogeneic hematopoietic stem cell transplantation

PROCEDURE

umbilical cord blood transplantation

RADIATION

total-body irradiation

RADIATION

Fractionated total body irradiation

Trial Locations (2)

85006

Banner Good Samaritan Medical Center, Phoenix

91010-3000

City of Hope Medical Center, Duarte

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00547196 - AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders | Biotech Hunter | Biotech Hunter